-
Mashup Score: 9Health Canada licenses Symplicity Spyral radiofrequency renal denervation system to treat hypertension - Vascular News - 28 day(s) ago
Medtronic has received a license from Health Canada for its Symplicity Spyral multi-electrode renal denervation (RDN) system. This is indicated for the management of essential hypertension in patients for whom blood pressure remains uncontrolled despite lifestyle modifications and guideline-driven medical therapy with antihypertensive medications, or when guideline-driven therapy is poorly tolerated. The Symplicity blood pressure […]
Source: vascularnews.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 265Top Stories in Nephrology 2023 — NephJC - 3 month(s) ago
2023 brought us has dogma shredding data on hyponatremia and the importance of different diuretics. It has new therapies for old diseases like IgA and hypertension. New drugs for new diseases like inaxaplin for AMKD. And it has new data on old debates like what IVF is best and do thiazides really pr
Source: www.nephjc.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 15Which were the Top Nephrology Stories of 2023? — NephJC - 4 month(s) ago
Time to vote for the Top Stories of 2023
Source: www.nephjc.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 15Which were the Top Nephrology Stories of 2023? — NephJC - 4 month(s) ago
Time to vote for the Top Stories of 2023
Source: www.nephjc.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 5News Details - 4 month(s) ago
Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis Bagsværd, Denmark, 10 October 2023 – Novo Nordisk today an nounced the decision to stop the kidney outcomes trial FLOW (Effect of semaglutide versus placebo on the progression of renal impairment in people with type 2 diabetes and chronic kidney disease). The decision to stop the trial is based on a recommendation from the independent Data Monitoring Committee (DMC) concluding that the
Source: www.novonordisk.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 8
PostSwapnil Hiremath @hswapnil@med-mastodon.com@hswapnilAlso see: incidence of ESRD is falling (left, actual count) But more importantly, the incidence rate has been falling for a while… (right) USDRS 202211:43 PM · Oct 10, 20232,525 Views2 Reposts1 Quote10 LikesNew to X?Sign up now to get your own personalized timeline!Sign up with AppleCreate accountBy signing up, you agree to the Terms of…
Source: x.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 0Top Nephrology Stories of 2022 - 1 year(s) ago
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 2Sequential Stem Cell–Kidney Transplantation in Schimke Immuno-osseous Dysplasia | NEJM - 1 year(s) ago
Original Article from The New England Journal of Medicine — Sequential Stem Cell–Kidney Transplantation in Schimke Immuno-osseous Dysplasia
Source: New England Journal of MedicineCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0Pipeline of Product Candidates | Kiniksa Pharmaceuticals - 2 year(s) ago
Learn about Kiniksa’s pipeline of product candidates for debilitating and devastating diseases.
Source: www.kiniksa.comCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 4The Top Nephrology Stories of 2021 — NephJC - 2 year(s) ago
It’s a tradition like no other. Top Ten Nephrology Stories of 2021
Source: NephJCCategories: Latest Headlines, NephrologyTweet
quickly following US FDA, @GovCanHealth also approves RDN in Canada (or atleast Medtronic SPYRAL) https://t.co/PAA5X8OeTM our write up from #TopNephrology here https://t.co/WEMDCPEEc1 https://t.co/9h7bTJBWi1